Investor Presentation May 2023

Strong Financial Performance US$ 1) 23 2) Accounting presentation change made to offset contributions to care and maintenance trust funds against revenue. Previously these contributions were presented within cost of sales. Calculated with respect to diluted shares outstanding at the respective reporting period. This is a non-IFRS financial measure. Please refer to the Appendix for more information on each non-IFRS financial measure Revenue ($M) (1) CAGR: 36.4% $241.1 $294.8 $178.6 $119.3 $64.5 $326.1 $329.7 2017 2018 2019 2020 2021 2022 TTM Q1 2023 YOY Growth 34.1% 85.0% 49.7% 35.0% 22.3% 10.6% 1.1% Net Earnings ($M) CAGR: 42.3% $27.8 $25.1 $21.0 $14.2 $3.3 $5.1 $5.2 2017 2018 2019 2020 2021 2022 TTM Q1 YOY 42.1% 54.5% 2.0% Growth 173.1% 95.8% -9.7% 2023 -16.3% Per Share (2) $0.25 $0.25 $0.19 $0.47 $0.88 $0.73 $0.61 Adjusted EBITDA ($M) (3) CAGR: 39.5% $59.5 $76.3 $74.9 $74.1 $40.2 $26.4 $12.9 2017 2018 2019 2020 2021 2022 YoY Growth 53.6% 104.7% 52.3% 48.0% 28.2% -1.8% TTM Q1 2023 -1.1% Per Share (2) $0.97 $1.28 $1.43 $1.99 $2.42 $2.16 $2.14 13

View entire presentation